Drug holidays recommended for low risk osteoporosis patients

Australian endocrinologists have cautiously welcomed new recommendations by the American Society for Bone and Mineral Research to consider drug holidays for people at low risk of osteoporotic fracture.

The recommendations suggest patients should be re-assessed for fracture risk after undertaking five years of oral bisphosphonates or three years of intravenous bisphosphonates.

Those at high risk who have a low